DOWLING & YAHNKE LLC - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is RGLS and the CUSIP is 75915K200. A total of 46 filers reported holding REGULUS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
DOWLING & YAHNKE LLC ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$4,0000.0%12,0000.0%0.00%
Q4 2021$4,000
-50.0%
12,0000.0%0.00%
Q3 2021$8,000
-20.0%
12,0000.0%0.00%
-100.0%
Q2 2021$10,000
-47.4%
12,0000.0%0.00%0.0%
Q1 2021$19,000
+18.8%
12,0000.0%0.00%0.0%
Q4 2020$16,000
+166.7%
12,0000.0%0.00%
Q3 2020$6,000
-25.0%
12,0000.0%0.00%
-100.0%
Q2 2020$8,00012,0000.00%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 1,450,777$1,180,0000.81%
Endurant Capital Management LP 2,607,674$2,120,0000.58%
Sarissa Capital Management LP 1,851,851$1,506,0000.12%
Ikarian Capital, LLC 1,245,989$1,014,0000.08%
NEA Management Company, LLC 6,451,056$5,225,0000.07%
Focused Wealth Management, Inc 200,000$163,0000.03%
GSA CAPITAL PARTNERS LLP 206,265$168,0000.02%
GYL FINANCIAL SYNERGIES, LLC 41,000$33,0000.02%
Virtu Financial LLC 79,193$64,0000.01%
Pinz Capital Management, LP 22,300$18,0000.01%
View complete list of REGULUS THERAPEUTICS INC shareholders